Showing 67,981 - 68,000 results of 125,008 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((mean decrease) OR (point decrease)) ))', query time: 1.82s Refine Results
  1. 67981

    Presentation1_The efficacy and safety of sacubitril/valsartan compared with ACEI/ARB in the treatment of heart failure following acute myocardial infarction: a systematic review an... by Jinquan Gao (16752399)

    Published 2023
    “…The pooled results demonstrated that patients in the SV group showed significantly better efficacy representing as increased LVEF [weighted mean difference (WMD): 4.43%, 95% confidence interval (CI): 2.84%–6.02%, p < 0.001] and 6MWT (WMD: 30.84 m, 95% CI: 25.65 m–36.03 m, p < 0.001) and decreased LVEDD (WMD: −3.24 mm, 95% CI: −4.96 mm ∼ -1.52 mm, p < 0.001) and NT-proBNP (WMD: −188.12 pg/mL, 95% CI: −246.75 pg/mL ∼ 129.49 pg/mL, p < 0.001), which was also verified by subgroup analysis based on the history of percutaneous coronary intervention (PCI). …”
  2. 67982

    Table 1_Biomechanical mechanisms of multidirectional dynamic compensatory muscle fatigue induced by abnormal cervical curvature: a cross-sectional case-control study based on surfa... by Rui Yang (293531)

    Published 2025
    “…Introduction<p>Cervical lordosis, a core indicator of spinal sagittal balance, is closely associated with cervical dysfunction when abnormal (straightening or kyphosis). …”
  3. 67983
  4. 67984

    Risk of upper gastrointestinal bleeding with low-dose aspirin: case–control studies and cohort studies. by Luis A. García Rodríguez (594336)

    Published 2016
    “…<sup>a</sup>Data for duodenal bleeding and gastric bleeding (defined as bleeds located in the upper gastrointestinal tract, at sites other than the duodenum) [≤ 250 and 251–325 mg per day]; <sup>b</sup>Data for plain, enteric-coated, and buffered aspirin; <sup>c</sup>Data for different alcohol consumption categories (current drinker/never drinker/ex-drinker); <sup>d</sup>Data for gastric ulcer and duodenal ulcer bleeding (defined as the presence of melena, haematemesis or haematochezia with a substantial decrease in haemoglobin and a peptic ulcer identified endoscopically); <sup>e</sup>Data for primary and secondary prevention; <sup>f</sup>Risk of erosive esophagitis; <sup>g</sup>Acute defined as regular or sporadic aspirin use for 5–30 days before endoscopy; <sup>h</sup>Chronic defined as regular aspirin use for more than 1 month before endoscopy; <sup>i</sup>OR; <sup>j</sup>RR; <sup>k</sup>SIR; <sup>l</sup>HR. …”
  5. 67985
  6. 67986

    Image2_Efficacy and Safety of Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease and Type 2 Diabetes: A Systematic Review Incorporating an... by Xinrui Jiang (6076712)

    Published 2022
    “…Compared with finerenone, esaxerenone showed no significant difference in UACR reduction (WMD 0.24, 95% CI −0.016 to 0.496, p = 0.869); apararenone and esaxerenone showed greater decreases in SBP (WMD 1.37, 95% CI 0.456 to 2.284, p = 0.010; WMD 3.11, 95% CI 0.544 to 5,676, p = 0.021).…”
  7. 67987

    Image1_Efficacy and Safety of Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease and Type 2 Diabetes: A Systematic Review Incorporating an... by Xinrui Jiang (6076712)

    Published 2022
    “…Compared with finerenone, esaxerenone showed no significant difference in UACR reduction (WMD 0.24, 95% CI −0.016 to 0.496, p = 0.869); apararenone and esaxerenone showed greater decreases in SBP (WMD 1.37, 95% CI 0.456 to 2.284, p = 0.010; WMD 3.11, 95% CI 0.544 to 5,676, p = 0.021).…”
  8. 67988

    Table1_Efficacy and Safety of Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease and Type 2 Diabetes: A Systematic Review Incorporating an... by Xinrui Jiang (6076712)

    Published 2022
    “…Compared with finerenone, esaxerenone showed no significant difference in UACR reduction (WMD 0.24, 95% CI −0.016 to 0.496, p = 0.869); apararenone and esaxerenone showed greater decreases in SBP (WMD 1.37, 95% CI 0.456 to 2.284, p = 0.010; WMD 3.11, 95% CI 0.544 to 5,676, p = 0.021).…”
  9. 67989

    Table2_Efficacy and Safety of Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease and Type 2 Diabetes: A Systematic Review Incorporating an... by Xinrui Jiang (6076712)

    Published 2022
    “…Compared with finerenone, esaxerenone showed no significant difference in UACR reduction (WMD 0.24, 95% CI −0.016 to 0.496, p = 0.869); apararenone and esaxerenone showed greater decreases in SBP (WMD 1.37, 95% CI 0.456 to 2.284, p = 0.010; WMD 3.11, 95% CI 0.544 to 5,676, p = 0.021).…”
  10. 67990
  11. 67991
  12. 67992
  13. 67993
  14. 67994
  15. 67995

    DataSheet1_Combing mechanical side-deep fertilization and controlled-release nitrogen fertilizer to increase nitrogen use efficiency by reducing ammonia volatilization in a double... by Zhaoming Chen (2615245)

    Published 2022
    “…Rice grain yields in the MRSF with CRF treatments increased by 3.9–17.3% in early rice and 5.4–21.6% in late rice relative to the CFB treatment. …”
  16. 67996
  17. 67997
  18. 67998
  19. 67999
  20. 68000